Financial Statements

West Pharmaceutical Services, Inc. (WST)


-8.36 (-2.74%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 1,8471,5491,3531,178-
Net Income 662346242207151
Stock Dividends -1-1-1101,067
Dividend Paid -51-48-45-42-39
Retained Earnings 2,4571,8471,5491,3531,178

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 1,012909822855-
Annual Depreciation 36927721472986
Capital Expenditure -253-174-126-105-131
Net PPE 1,1271,012909822855

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -108106108111
New Purchases -----
Intangible and Goodwill 108106108111110

West Pharmaceutical Services, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes West Pharmaceutical Services, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.